Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Smoking Cessation 1Recurrence 1Neoplasms 1Carcinoma in Situ 1

Interventions

fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Tacrolimus 2Surveys and Questionnaires 2Proton Therapy 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Music Therapy 2Mesna 2Melphalan 2Interviews as Topic 2Gene Expression Profiling 2Cyclophosphamide 2Busulfan 2tremelimumab 1motesanib diphosphate 1luprolide acetate gel depot 1liposomal amphotericin B 1durvalumab 1copanlisib 1chlorhexidine gluconate 1batifiban 1Whole Genome Sequencing 1Watchful Waiting 1Thrombopoietin 1Taxes 1Spermine Synthase 1Radiotherapy, Intensity-Modulated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neoplasms × Nicotine Replacement Therapy × Clear all
NCT03808818 2025-03-18

Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices

Eastern Cooperative Oncology Group

Phase NA Completed
306 enrolled 20 charts

Carcinoma in Situ, Neoplasms, Recurrence, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡